Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses Meeting Abstract
| Authors: | Doshi, S. D.; Sanmiguel, A. L.; Knezevic, A.; Kotecha, R. R.; Shah, N. J.; Carlo, M.; Feldman, D. R.; Motzer, R. J.; Voss, M. H. |
| Abstract Title: | Outcomes with first-line ipilimumab and nivolumab for patients with metastatic renal cell carcinoma by number of doses |
| Meeting Title: | 2025 ASCO Genitourinary Cancers Symposium |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 43 |
| Issue: | 5 Suppl. |
| Meeting Dates: | 2025 Feb 13-15 |
| Meeting Location: | San Francisco, CA |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2025-02-10 |
| Language: | English |
| ACCESSION: | WOS:001454684700019 |
| DOI: | 10.1200/JCO.2025.43.5_suppl.540 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 540 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
